Ashleigh Tinotenda Chitakunye, Odinaka Cassandra Ezekiel, Qin Liu, Shihui Zhang, Qin Zhu and Lin Cai
{"title":"黑色素瘤治疗的创新方法:聚焦于刺激反应生物材料。","authors":"Ashleigh Tinotenda Chitakunye, Odinaka Cassandra Ezekiel, Qin Liu, Shihui Zhang, Qin Zhu and Lin Cai","doi":"10.1039/D4TB01504E","DOIUrl":null,"url":null,"abstract":"<p >Melanoma presents as an increasingly prevalent and intricate skin cancer, characterized by a complex tumor microenvironment that features various mutations and the activation of melanogenesis pathways. Dynamic changes within this microenvironment, including increased ROS levels, acidity, and enzyme expression, specifically upregulation of glutaryl-CoA dehydrogenase and MMP2, amongst other enzymes, further contribute to its complexity. Despite advancements in melanoma treatment and FDA approval of therapies targeting specific pathways and employing immune checkpoint inhibitors, challenges persist in melanoma treatment, particularly in optimizing drug delivery and navigating the intricate tumor microenvironment. Recent research has increasingly focused on integrating biomaterials into melanoma treatment, yielding promising results. These biomaterials find application in melanoma diagnosis, treatment, and imaging. Studies have sparked interest in uncovering the therapeutic potential of stimuli-responsive biomaterials. pH-responsive systems offer the prospect of targeted drug release in the acidic tumor microenvironment. Meanwhile, light- and temperature-responsive materials offer spatiotemporal control, aiding melanoma death processes such as necroptosis, apoptosis, and necrosis. Biomaterials responsive to ROS and enzymes address the intricacies of melanoma biology, enhancing treatment specificity. Additionally, multiple stimuli-responsive platforms present a holistic approach for heightened therapeutic efficacy. This review navigates the intricate terrain of melanoma treatment, addressing current therapy limitations and envisioning a future where functionalized biomaterials are pivotal in more effective and targeted interventions. We evaluate multifaceted approaches harnessing distinct biological, physical, and chemical stimuli, and their synergistic combinations to enhance drug delivery precision and other mechanisms in melanoma.</p>","PeriodicalId":83,"journal":{"name":"Journal of Materials Chemistry B","volume":" 36","pages":" 11102-11125"},"PeriodicalIF":6.1000,"publicationDate":"2025-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Innovative approaches to melanoma treatment: a spotlight on stimuli-responsive biomaterials\",\"authors\":\"Ashleigh Tinotenda Chitakunye, Odinaka Cassandra Ezekiel, Qin Liu, Shihui Zhang, Qin Zhu and Lin Cai\",\"doi\":\"10.1039/D4TB01504E\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >Melanoma presents as an increasingly prevalent and intricate skin cancer, characterized by a complex tumor microenvironment that features various mutations and the activation of melanogenesis pathways. Dynamic changes within this microenvironment, including increased ROS levels, acidity, and enzyme expression, specifically upregulation of glutaryl-CoA dehydrogenase and MMP2, amongst other enzymes, further contribute to its complexity. Despite advancements in melanoma treatment and FDA approval of therapies targeting specific pathways and employing immune checkpoint inhibitors, challenges persist in melanoma treatment, particularly in optimizing drug delivery and navigating the intricate tumor microenvironment. Recent research has increasingly focused on integrating biomaterials into melanoma treatment, yielding promising results. These biomaterials find application in melanoma diagnosis, treatment, and imaging. Studies have sparked interest in uncovering the therapeutic potential of stimuli-responsive biomaterials. pH-responsive systems offer the prospect of targeted drug release in the acidic tumor microenvironment. Meanwhile, light- and temperature-responsive materials offer spatiotemporal control, aiding melanoma death processes such as necroptosis, apoptosis, and necrosis. Biomaterials responsive to ROS and enzymes address the intricacies of melanoma biology, enhancing treatment specificity. Additionally, multiple stimuli-responsive platforms present a holistic approach for heightened therapeutic efficacy. This review navigates the intricate terrain of melanoma treatment, addressing current therapy limitations and envisioning a future where functionalized biomaterials are pivotal in more effective and targeted interventions. We evaluate multifaceted approaches harnessing distinct biological, physical, and chemical stimuli, and their synergistic combinations to enhance drug delivery precision and other mechanisms in melanoma.</p>\",\"PeriodicalId\":83,\"journal\":{\"name\":\"Journal of Materials Chemistry B\",\"volume\":\" 36\",\"pages\":\" 11102-11125\"},\"PeriodicalIF\":6.1000,\"publicationDate\":\"2025-08-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Materials Chemistry B\",\"FirstCategoryId\":\"1\",\"ListUrlMain\":\"https://pubs.rsc.org/en/content/articlelanding/2025/tb/d4tb01504e\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MATERIALS SCIENCE, BIOMATERIALS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Materials Chemistry B","FirstCategoryId":"1","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2025/tb/d4tb01504e","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
Innovative approaches to melanoma treatment: a spotlight on stimuli-responsive biomaterials
Melanoma presents as an increasingly prevalent and intricate skin cancer, characterized by a complex tumor microenvironment that features various mutations and the activation of melanogenesis pathways. Dynamic changes within this microenvironment, including increased ROS levels, acidity, and enzyme expression, specifically upregulation of glutaryl-CoA dehydrogenase and MMP2, amongst other enzymes, further contribute to its complexity. Despite advancements in melanoma treatment and FDA approval of therapies targeting specific pathways and employing immune checkpoint inhibitors, challenges persist in melanoma treatment, particularly in optimizing drug delivery and navigating the intricate tumor microenvironment. Recent research has increasingly focused on integrating biomaterials into melanoma treatment, yielding promising results. These biomaterials find application in melanoma diagnosis, treatment, and imaging. Studies have sparked interest in uncovering the therapeutic potential of stimuli-responsive biomaterials. pH-responsive systems offer the prospect of targeted drug release in the acidic tumor microenvironment. Meanwhile, light- and temperature-responsive materials offer spatiotemporal control, aiding melanoma death processes such as necroptosis, apoptosis, and necrosis. Biomaterials responsive to ROS and enzymes address the intricacies of melanoma biology, enhancing treatment specificity. Additionally, multiple stimuli-responsive platforms present a holistic approach for heightened therapeutic efficacy. This review navigates the intricate terrain of melanoma treatment, addressing current therapy limitations and envisioning a future where functionalized biomaterials are pivotal in more effective and targeted interventions. We evaluate multifaceted approaches harnessing distinct biological, physical, and chemical stimuli, and their synergistic combinations to enhance drug delivery precision and other mechanisms in melanoma.
期刊介绍:
Journal of Materials Chemistry A, B & C cover high quality studies across all fields of materials chemistry. The journals focus on those theoretical or experimental studies that report new understanding, applications, properties and synthesis of materials. Journal of Materials Chemistry A, B & C are separated by the intended application of the material studied. Broadly, applications in energy and sustainability are of interest to Journal of Materials Chemistry A, applications in biology and medicine are of interest to Journal of Materials Chemistry B, and applications in optical, magnetic and electronic devices are of interest to Journal of Materials Chemistry C.Journal of Materials Chemistry B is a Transformative Journal and Plan S compliant. Example topic areas within the scope of Journal of Materials Chemistry B are listed below. This list is neither exhaustive nor exclusive:
Antifouling coatings
Biocompatible materials
Bioelectronics
Bioimaging
Biomimetics
Biomineralisation
Bionics
Biosensors
Diagnostics
Drug delivery
Gene delivery
Immunobiology
Nanomedicine
Regenerative medicine & Tissue engineering
Scaffolds
Soft robotics
Stem cells
Therapeutic devices